SC 13D | 2024-05-08 | Exploration Capital, LLC | Fresh Tracks Therapeutics, Inc. | 1,226,024 | 20.5% | EDGAR |
SC 13G/A | 2024-01-18 | Exploration Capital, LLC | Fresh Tracks Therapeutics, Inc. | 850,000 | 14.2% | EDGAR |
SC 13G | 2023-11-28 | Exploration Capital Fund, LP | Fresh Tracks Therapeutics, Inc. | - | 10.0% | EDGAR |
SC 13G/A | 2023-02-13 | Ionic Ventures, LLC | Fresh Tracks Therapeutics, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2022-02-03 | Ionic Ventures, LLC | Brickell Biotech, Inc. | 6,094,994 | 5.3% | EDGAR |
SC 13G/A | 2021-11-03 | Ionic Ventures, LLC | Brickell Biotech, Inc. | 7,286,066 | 6.3% | EDGAR |
SC 13G | 2021-07-22 | Ionic Ventures, LLC | Brickell Biotech, Inc. | 4,708,050 | 5.7% | EDGAR |
SC 13G/A | 2021-02-16 | CVI Investments, Inc. | Brickell Biotech, Inc. | 2,810,675 | 4.9% | EDGAR |
SC 13G/A | 2021-02-11 | BIOTECHNOLOGY VALUE FUND L P | Brickell Biotech, Inc. | - | 0.0% | EDGAR |
SC 13D/A | 2020-09-24 | Palisade Concentrated Equity Partnership II, LP | Brickell Biotech, Inc. | 1,073,374 | - | EDGAR |
SC 13G | 2020-06-26 | ARMISTICE CAPITAL, LLC | Brickell Biotech, Inc. | 1,331,248 | 5.0% | EDGAR |
SC 13G | 2020-06-26 | CVI Investments, Inc. | Brickell Biotech, Inc. | 1,930,054 | 7.9% | EDGAR |
SC 13G | 2020-02-27 | Lincoln Park Capital Fund, LLC | Brickell Biotech, Inc. | 965,723 | 10.0% | EDGAR |
SC 13G/A | 2020-02-14 | ARMISTICE CAPITAL, LLC | Brickell Biotech, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-02-14 | BIOTECHNOLOGY VALUE FUND L P | Brickell Biotech, Inc. | 346,254 | 4.4% | EDGAR |
SC 13G/A | 2020-02-14 | Sio Capital Management, LLC | Brickell Biotech, Inc. | - | 0.0% | EDGAR |
SC 13G/A | 2020-02-11 | UBS Group AG | Brickell Biotech, Inc. | - | - | EDGAR |
SC 13D | 2019-09-16 | Palisade Concentrated Equity Partnership II, LP | Brickell Biotech, Inc. | 1,013,232 | - | EDGAR |
SC 13G | 2019-04-08 | BIOTECHNOLOGY VALUE FUND L P | VICAL INC | 798,415 | 3.5% | EDGAR |
SC 13D/A | 2019-03-19 | BIOTECHNOLOGY VALUE FUND L P | VICAL INC | 798,415 | 3.5% | EDGAR |